Groundbreaking research shows that a simple blood test can detect symptoms of Alzheimer’s disease (AD) up to 15 years in advance, according to a report in the Times of London.
Neurological scientists at the University of Gothenburg in Sweden have found ways to simply analyze the residue of a protein known as phosphorylated Tau 217 (pTau 217), which is commonly associated with the disease known as phosphorylated Tau 217 (pTau 217), with results ” impressive.” results.
The testing procedure, called an assay, was created by the company ALZpath and offers a comparatively painless and less expensive alternative to lumbar punctures to understand a person’s risk of developing the disease, according to a study published in the Journal of the American Medical Association.
“ALZpath’s pTau217 test can help healthcare providers determine the presence of amyloid plaques in the brain, a hallmark of Alzheimer’s disease,” said Dr. Andreas Jeromin, chief scientific officer of ALZpath.
Three independent clinical studies of 786 patients demonstrated that ALZpath offers “high diagnostic accuracy” in identifying AD-inducing proteins within the brain, such as amyloid plaques.
A blood test appears to be a breakthrough in detecting Alzheimer’s disease. Getty Images/iStockphoto A blood test can now find clues to Alzheimer’s disease years in advance, according to a report in the Times of London. Via REUTERS
The company announced that its latest breakthrough will be available for clinical use in late January and will also be available commercially (CNN reported a price between $200 and $500) at some point.
“This is an instrumental finding in blood biomarkers for Alzheimer’s, paving the way for clinical use of the ALZpath pTau 217 assay,” researchers Kaj Blennow and Henrik Zetterberg said in a statement, adding that the “robust” assay is already It is in use in several laboratories around the world.
“What’s impressive about these results is that the blood test was as accurate as advanced tests like cerebrospinal fluid tests and brain scans in showing the pathology of Alzheimer’s disease in the brain,” lead author told CNN. Nicholas Ashton.
“We are now close to these tests hitting prime time and this study proves it.”
Researchers predict that the blood test will be a breakthrough in the treatment of Alzheimer’s disease. AFP via Getty Images The blood test also offers cost-effectiveness compared to lumbar punctures. AP
Last year, the Massachusetts Institute of Technology designed a peptide (a chain of amino acids) to also interact with and repair the brain’s tau protein.
Separate research also found that taking multivitamins could also prevent dementia.
Categories: Trending
Source: vtt.edu.vn